Pediatr Dermatol. 2007 Sep-Oct;24(5):E40-3.

Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.

Source

National Skin Centre, Singapore. jeanho@nsc.gov.sg

Abstract

Linear immunoglobulin A bullous disease is an autoimmune subepidermal blistering disease that has been described in both children and adults. Reports have shown that as many as two-thirds of occurrences may be drug-induced. The offending drugs include antibiotics, predominantly vancomycin, nonsteroidal anti-inflammatory agents and diuretics. We report childhood linear immunoglobulin A bullous dermatosis developing following amoxicillin-clavulanic acid administration. The patient presented with characteristic blisters in an annular fashion, likened to a ''crown of jewels.'' The diagnosis was confirmed by the presence of a linear band of immunoglobulin A at the dermoepidermal junction on direct immunofluorescence. The lesions resolved with withdrawal of the drug, and systemic therapy was not required. We review the current literature and concepts of drug-induced linear immunoglobulin A bullous disease.

PMID:: 17958778; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Case Reports

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Related citations

A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis. [Arch Dermatol. 2008]
A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
Billet SE, Kortuem KR, Gibson LE, El-Azhary R. Arch Dermatol. 2008 Jun; 144(6):774-8.
Amoxicillin-clavulanic acid-induced linear immunoglobulin A bullous dermatosis: case report and review of the literature. [Int J Dermatol. 2009]
Amoxicillin-clavulanic acid-induced linear immunoglobulin A bullous dermatosis: case report and review of the literature.
Panasiti V, Rossi M, Devirgiliis V, Curzio M, Bottoni U, Calvieri S. Int J Dermatol. 2009 Sep; 48(9):1006-10.
Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis. [J Drugs Dermatol. 2008]
Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
Kovacic D, Fox M, Reichenberg J. J Drugs Dermatol. 2008 Aug; 7(8):794-5.
Review Drug-induced linear IgA bullous dermatosis. [J Dermatol. 2005]
Review Drug-induced linear IgA bullous dermatosis.
Onodera H, Mihm MC Jr, Yoshida A, Akasaka T. J Dermatol. 2005 Sep; 32(9):759-64.
Review [Drug induced linear IgA bullous dermatosis]. [Nephrologie. 2003]
Review [Drug induced linear IgA bullous dermatosis].
Montagnac R, Reguiaï Z, Méhaut S, Bressieux JM, Schillinger F. Nephrologie. 2003; 24(6):287-92.

See reviews... See all...

Cited by 1 PubMed Central article

Childhood linear IgA bullous disease induced by trimethoprim-sulfamethoxazole. [J Dermatol Case Rep. 2010]
Childhood linear IgA bullous disease induced by trimethoprim-sulfamethoxazole.
Nantel-Battista M, Al Dhaybi R, Hatami A, Marcoux D, Desroches A, Kokta V. J Dermatol Case Rep. 2010 Dec 19; 4(3):33-5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.
Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.
Pediatr Dermatol. 2007 Sep-Oct ;24(5):E40-3.

PubMed
Longitudinal quality of life data can provide insights on the impact of adjuvant...
Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-Subset analysis of the ESPAC-1 data.
Int J Cancer. 2009 Jun 15 ;124(12):2960-5.

PubMed
Addressing the efficacy of dihydrocodeine versus methadone as an alternative mai...
Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
Addiction. 2006 Dec ;101(12):1752-9.

PubMed
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of ir...
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.
Cancer Invest. 2009 May ;27(4):402-6.

PubMed
Dextromethorphan: another "ecstasy"?
Dextromethorphan: another "ecstasy"?
Arch Fam Med. 2000 Feb ;9(2):123.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: